Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Haema is the largest private blood and plasma donation service in Germany, operating a vast network of donation centers across the country. The company specializes in the collection of blood and blood plasma, which serve as essential raw materials for the production of life-saving biopharmaceutical products. Following its acquisition by Grifols in 2018, Haema plays a critical role in the global supply chain for plasma-derived therapies used to treat rare and chronic conditions such as immunodeficiencies and coagulation disorders. In addition to plasma collection, the company provides comprehensive transfusion medicine services and laboratory diagnostics to hospitals and medical facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Haema Research.